Transcriptional profiling sheds light on the fibrotic aspects of idiopathic subglottic tracheal stenosis.
Schwann cells
fibroblasts
idiopathic subglottic stenosis
matrix
plasma cells
single cell RNA sequencing
trachea
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2024
2024
Historique:
received:
02
02
2024
accepted:
25
06
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
epublish
Résumé
Idiopathic subglottic stenosis (ISGS) is a rare fibrotic disease of the upper trachea with an unknown pathomechanism. It typically affects adult Caucasian female patients, leading to severe airway constrictions caused by progressive scar formation and inflammation with clinical symptoms of dyspnoea, stridor and potential changes to the voice. Endoscopic treatment frequently leads to recurrence, whereas surgical resection and reconstruction provides excellent long-term functional outcome. This study aimed to identify so far unrecognized pathologic aspects of ISGS using single cell RNA sequencing. Our scRNAseq analysis uncovered the cellular composition of the subglottic scar tissue, including the presence of a pathologic, profibrotic fibroblast subtype and the presence of Schwann cells in a profibrotic state. In addition, a pathology-associated increase of plasma cells was identified. Using extended bioinformatics analyses, we decoded pathology-associated changes of factors of the extracellular matrix. Our data identified ongoing fibrotic processes in ISGS and provide novel insights on the contribution of fibroblasts, Schwann cells and plasma cells to the pathogenesis of ISGS. This knowledge could impact the development of novel approaches for diagnosis and therapy of ISGS.
Identifiants
pubmed: 39071799
doi: 10.3389/fcell.2024.1380902
pii: 1380902
pmc: PMC11272577
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1380902Informations de copyright
Copyright © 2024 Direder, Laggner, Copic, Klas, Bormann, Schweiger, Hoetzenecker, Aigner, Ankersmit and Mildner.
Déclaration de conflit d'intérêts
Authors MD, ML, DC, KK, DB, and HA were employed by Aposcience AG. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.